Literature DB >> 7729916

Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.

M Desjardins1, L G Filion, S Robertson, D W Cameron.   

Abstract

Using the temperature-dependent rabbit model of Haemophilus ducreyi infection as a quantitative virulence assay, we tested the abilities of two bacterial antigen preparations to induce protection against subsequent infection and disease. Lipooligosaccharide (LOS) and a pilus preparation were purified from H. ducreyi 35000 and were used in a booster immunization procedure. The serologic response to each immunogen was monitored by enzyme immunoassay. H. ducreyi virulence was assayed by intraepithelial inoculation and subsequent measurement of disease for homologous strain 35000 or clinical isolate RO-34. LOS and the pilus preparation induced humoral responses. The kinetics of the LOS antibody response suggest a type 1 T-independent response, whereas the pilus preparation induced an anamnestic response. An inoculum of 10(5) CFU of H. ducreyi 35000 or RO-34 consistently produced ulcerative chancroidal lesions in naive rabbit controls. Immunization with LOS did not modify the virulence of H. ducreyi 35000. Immunization with the strain 35000 pilus preparation significantly reduced the severity of disease and the duration of infection and disease compared with controls, with either homologous or heterologous strain infection. The histology of lesions from pilus preparation-vaccinated rabbits compared with that of lesions from controls revealed accelerated lymphoid cell recruitment, more prominent plasma cell infiltrate, and reduction in subsequent histiocytic infiltration. We conclude that both LOS and the pilus preparation are immunogenic and that the latter induces homologous and heterologous strain protection in this animal model of infection and disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729916      PMCID: PMC173258          DOI: 10.1128/iai.63.5.2012-2020.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  Advances in the diagnosis and management of chancroid.

Authors:  L J D'Costa; I Bowmer; H Nsanze; J Dylewski; L Fransen; F A Plummer; P Piot; A R Ronald
Journal:  Sex Transm Dis       Date:  1986 Jul-Sep       Impact factor: 2.830

Review 2.  Chancroid and the role of genital ulcer disease in the spread of human retroviruses.

Authors:  P G Jessamine; A R Ronald
Journal:  Med Clin North Am       Date:  1990-11       Impact factor: 5.456

3.  Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya.

Authors:  P J Plourde; F A Plummer; J Pepin; E Agoki; G Moss; J Ombette; A R Ronald; M Cheang; L D'Costa; J O Ndinya-Achola
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

4.  Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.

Authors:  M J Alfa; N Olson; P Degagne; F Plummer; W Namaara; I Maclean; A R Ronald
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

5.  The clinical diagnosis of genital ulcer disease in men in the tropics.

Authors:  M V Fast; L J D'Costa; H Nsanze; P Piot; J Curran; P Karasira; N Mirza; I W Maclean; A R Ronald
Journal:  Sex Transm Dis       Date:  1984 Apr-Jun       Impact factor: 2.830

6.  Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

7.  A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.

Authors:  B K Purcell; J A Richardson; J D Radolf; E J Hansen
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

8.  Characterization of pili expressed by Haemophilus ducreyi.

Authors:  S M Spinola; A Castellazzo; M Shero; M A Apicella
Journal:  Microb Pathog       Date:  1990-12       Impact factor: 3.738

9.  Ceftriaxone no longer predictably cures chancroid in Kenya.

Authors:  M Tyndall; M Malisa; F A Plummer; J Ombetti; J O Ndinya-Achola; A R Ronald
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi.

Authors:  M Desjardins; C E Thompson; L G Filion; J O Ndinya-Achola; F A Plummer; A R Ronald; P Piot; D W Cameron
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  6 in total

1.  Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

Authors:  K L Thomas; I Leduc; B Olsen; C E Thomas; D W Cameron; C Elkins
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin.

Authors:  S M Dutro; G E Wood; P A Totten
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Authors:  Galyna Afonina; Isabelle Leduc; Igor Nepluev; Chrystina Jeter; Patty Routh; Glen Almond; Paul E Orndorff; Marcia Hobbs; Christopher Elkins
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.

Authors:  M Desjardins; L G Filion; S Robertson; L Kobylinski; D W Cameron
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

6.  Fine tangled pili expressed by Haemophilus ducreyi are a novel class of pili.

Authors:  R J Brentjens; M Ketterer; M A Apicella; S M Spinola
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.